[go: up one dir, main page]

HK1188129B - 包含决奈达隆的药物组合物和剂型,及其制备方法 - Google Patents

包含决奈达隆的药物组合物和剂型,及其制备方法 Download PDF

Info

Publication number
HK1188129B
HK1188129B HK14101204.4A HK14101204A HK1188129B HK 1188129 B HK1188129 B HK 1188129B HK 14101204 A HK14101204 A HK 14101204A HK 1188129 B HK1188129 B HK 1188129B
Authority
HK
Hong Kong
Prior art keywords
composition according
benzoyl
butylaminopropoxy
butyl
composition
Prior art date
Application number
HK14101204.4A
Other languages
German (de)
English (en)
French (fr)
Other versions
HK1188129A (zh
Inventor
Bernard Abramovici
Stéphane Beilles
Jean-Claude Gautier
Sandra Chambonnet
Original Assignee
Sanofi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi filed Critical Sanofi
Publication of HK1188129A publication Critical patent/HK1188129A/zh
Publication of HK1188129B publication Critical patent/HK1188129B/zh

Links

HK14101204.4A 2010-11-10 2011-11-10 包含决奈达隆的药物组合物和剂型,及其制备方法 HK1188129B (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1059306 2010-11-10

Publications (2)

Publication Number Publication Date
HK1188129A HK1188129A (zh) 2014-04-25
HK1188129B true HK1188129B (zh) 2019-02-01

Family

ID=

Similar Documents

Publication Publication Date Title
JP7627302B2 (ja) パルボシクリブの固形剤形
JP3889481B2 (ja) 医薬組成物
KR910004572B1 (ko) 경구용 당뇨병 치료제 제형의 제조방법
NO329912B1 (no) Sammensetninger omfattende celecoxib
JP2024508737A (ja) 疾患を治療するための方法および医薬組成物
US20150196528A1 (en) Pharmaceutical composition and dosage form comprising dronedarone, and preparation method thereof
WO2023139464A1 (en) A liquid pharmaceutical formulation of clonidine hydrochloride
EP2510924B1 (en) SOLID DISPERSIONS CONTAINING 20-O-ß-D-GLUCOPYRANOSYL-20(S)-PROTOPANAXADIOL
MX2013013575A (es) Composicion farmaceutica que comprende fenofenadina.
HK1188129B (zh) 包含决奈达隆的药物组合物和剂型,及其制备方法
WO2016084099A1 (en) Soft gelatin capsule composition of anti-tussive agents
US20100221326A1 (en) Pharmaceutical compositions for oral use for treating patients affected by obesity
HK1188129A (zh) 包含决奈达隆的药物组合物和剂型,及其制备方法
JP4866170B2 (ja) 睡眠薬の放出制御医薬組成物及びその製造方法
JP2023529001A (ja) 結晶形のラベキシモドを含む経口製剤
DK166947B1 (da) Forbedrede piroxicamholdige praeparater med antiinflammatorisk virkning
KR100201907B1 (ko) 비페닐디메틸디카르복실레이트를 가용화시킨 연질캅셀제
WO2024102699A1 (en) Guanylate cyclase (gc) stimulator formulations and uses thereof
JP2004527447A (ja) 無水パロキセチン用安定製剤形
WO2015010217A1 (en) Dimiracetam in the treatment of depression
KR20050034299A (ko) 아세클로페낙 자가유화에멀젼 및 이를 이용한 연질캅셀제조성물 및 그의 제조방법
TW201311239A (zh) 包含非索非那定(fexofenadine)之醫藥組成物
KR20190038027A (ko) 아세트아미노펜, 및 트라마돌 또는 이의 약학적 허용 가능한 염을 포함하는 연질캡슐 조성물
JP2006111641A (ja) 医薬組成物
JP2006257107A (ja) 医薬組成物